Literature DB >> 25619881

Effects of ceftriaxone on GLT1 isoforms, xCT and associated signaling pathways in P rats exposed to ethanol.

P S S Rao1, Hannah Saternos1, Sunil Goodwani1, Youssef Sari2.   

Abstract

RATIONALE: Several studies have demonstrated a correlation between extracellular glutamate concentration in the mesolimbic reward pathway and alcohol craving. Extracellular glutamate concentration is regulated by several glutamate transporters. Glial glutamate transporter 1 (GLT1) is one of them that regulates the majority of extracellular glutamate concentration. In addition, cystine/glutamate antiporter (xCT) is another transporter that regulates extracellular glutamate.
OBJECTIVES: We focus in this study to determine the effects of ceftriaxone, β-lactam antibiotic, on glial proteins such as GLT1 isoforms, xCT, glutamate aspartate transporter (GLAST), and several associated signaling pathways as well as ethanol intake in P rats. Additionally, to examine the onset of signaling pathways associated with GLT1 upregulation following ceftriaxone treatment, we tested 2- versus 5-day daily dosing of ceftriaxone.
RESULTS: Ceftriaxone treatment (100 mg/kg), 2 and 5 days, resulted in about five fold reduction in ethanol intake by P rats. The reduction in ethanol intake was associated with significantly enhanced expression of GLT1, GLT1a, GLT1b, and xCT in the nucleus accumbens (NAc) and prefrontal cortex (PFC) of 5-day ceftriaxone-treated P rats. Two-day-treated P rats showed marked changes in expression of these glutamate transporters in the PFC but not in the NAc. Importantly, ceftriaxone-treated P rats (2 and 5 days) demonstrated enhanced phosphorylation of Akt and nuclear translocation of nuclear factor kappaB (NFκB) in the NAc and PFC compared to control animals.
CONCLUSIONS: These findings demonstrate that ceftriaxone treatment induced upregulation of GLT1, GLT1 isoforms, and xCT in association with activation of the Akt-NFκB signaling pathway.

Entities:  

Keywords:  Ceftriaxone; EAAT2; GLT1; Glutamate; Nucleus accumbens; P rats; Prefrontal cortex

Mesh:

Substances:

Year:  2015        PMID: 25619881      PMCID: PMC4465848          DOI: 10.1007/s00213-015-3868-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  68 in total

1.  Ethanol exposure decreases glutamate uptake in the nucleus accumbens.

Authors:  Roberto I Melendez; Megan P Hicks; Stephanie S Cagle; Peter W Kalivas
Journal:  Alcohol Clin Exp Res       Date:  2005-03       Impact factor: 3.455

2.  Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype.

Authors:  Li-Bin Li; Shuy Vang Toan; Olga Zelenaia; Deborah J Watson; John H Wolfe; Jeffrey D Rothstein; Michael B Robinson
Journal:  J Neurochem       Date:  2006-03-29       Impact factor: 5.372

3.  Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations.

Authors:  Y Li; X T Hu; T G Berney; A J Vartanian; C D Stine; M E Wolf; F J White
Journal:  Synapse       Date:  1999-12       Impact factor: 2.562

4.  Cocaine-induced plasticity of intrinsic membrane properties in prefrontal cortex pyramidal neurons: adaptations in potassium currents.

Authors:  Yan Dong; Fernando J Nasif; Jennifer J Tsui; William Y Ju; Donald C Cooper; Xiu-Ti Hu; Robert C Malenka; Francis J White
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

5.  A new GLT1 splice variant: cloning and immunolocalization of GLT1c in the mammalian retina and brain.

Authors:  Thomas Rauen; Michael Wiessner; Robert Sullivan; Aven Lee; David V Pow
Journal:  Neurochem Int       Date:  2004-12       Impact factor: 3.921

6.  Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.

Authors:  B R Miller; J L Dorner; M Shou; Y Sari; S J Barton; D R Sengelaub; R T Kennedy; G V Rebec
Journal:  Neuroscience       Date:  2008-02-15       Impact factor: 3.590

7.  Presynaptic regulation of astroglial excitatory neurotransmitter transporter GLT1.

Authors:  Yongjie Yang; Oguz Gozen; Andrew Watkins; Ileana Lorenzini; Angelo Lepore; Yuanzheng Gao; Svetlana Vidensky; Jean Brennan; David Poulsen; Jeong Won Park; Noo Li Jeon; Michael B Robinson; Jeffrey D Rothstein
Journal:  Neuron       Date:  2009-03-26       Impact factor: 17.173

8.  Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats.

Authors:  Youssef Sari; Sai N Sreemantula; Moonnoh R Lee; Doo-Sup Choi
Journal:  J Mol Neurosci       Date:  2013-07-27       Impact factor: 3.444

9.  Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes.

Authors:  Seok-Geun Lee; Zhao-Zhong Su; Luni Emdad; Pankaj Gupta; Devanand Sarkar; Alejandra Borjabad; David J Volsky; Paul B Fisher
Journal:  J Biol Chem       Date:  2008-03-07       Impact factor: 5.157

10.  Altered expression of the glutamate transporter EAAT2b in neurological disease.

Authors:  Nicholas J Maragakis; Margaret Dykes-Hoberg; Jeffrey D Rothstein
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

View more
  26 in total

Review 1.  Biogenesis, physiological functions and potential applications of extracellular vesicles in substance use disorders.

Authors:  Ernest T Chivero; Raghubendra Singh Dagur; Eric S Peeples; Susmita Sil; Ke Liao; Rong Ma; Liang Chen; Channabasavaiah B Gurumurthy; Shilpa Buch; Guoku Hu
Journal:  Cell Mol Life Sci       Date:  2021-04-05       Impact factor: 9.261

2.  Effects of ampicillin, cefazolin and cefoperazone treatments on GLT-1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats.

Authors:  P S S Rao; S Goodwani; R L Bell; Y Wei; S H S Boddu; Y Sari
Journal:  Neuroscience       Date:  2015-03-24       Impact factor: 3.590

Review 3.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

4.  Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior.

Authors:  Alaa M Hammad; Fawaz Alasmari; Yusuf S Althobaiti; Youssef Sari
Journal:  Behav Brain Res       Date:  2017-06-15       Impact factor: 3.332

Review 5.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

6.  β-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats.

Authors:  Alqassem Y Hakami; Youssef Sari
Journal:  Neurosci Lett       Date:  2017-08-05       Impact factor: 3.046

Review 7.  The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.

Authors:  Edward Pajarillo; Asha Rizor; Jayden Lee; Michael Aschner; Eunsook Lee
Journal:  Neuropharmacology       Date:  2019-03-06       Impact factor: 5.250

Review 8.  Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence.

Authors:  Fawaz Alasmari; Sunil Goodwani; Robert E McCullumsmith; Youssef Sari
Journal:  Prog Neurobiol       Date:  2018-10-11       Impact factor: 11.685

9.  Effects of Cocaine Exposure on Astrocytic Glutamate Transporters and Relapse-Like Ethanol-Drinking Behavior in Male Alcohol-Preferring Rats.

Authors:  Alaa M Hammad; Youssef Sari
Journal:  Alcohol Alcohol       Date:  2020-04-16       Impact factor: 2.826

10.  Effects of ceftriaxone on ethanol, nicotine or sucrose intake by alcohol-preferring (P) rats and its association with GLT-1 expression.

Authors:  Youssef Sari; Jamie E Toalston; P S S Rao; Richard L Bell
Journal:  Neuroscience       Date:  2016-04-07       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.